1Department of Biostatistics and Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
2Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran
3Center for Disease Control & Prevention, Deputy of Health Services, Hamadan University of Medical Sciences, Hamadan, Iran
Background Epidemiological information on tuberculosis (TB) is required to plan control and prevention strategies and to inform service delivery systems. The aim of present study was to determine the epidemiological status of TB in Hamadan Province covering a seven-year period.
Methods In this cross-sectional study all registered TB patients suffering from any form of smear-positive, smear-negative or extra pulmonary from 2005 to 2011 were assessed. Age-adjusted incidence trend was studied. The Cochran-Armitage (C-A) test was used for testing the trends over time.
Results The mean age of TB patients was 57.0 (±21.1), 49.9% were males, 52.8% were aged 61 years or older and 39.7% were rural residents. Previous history of jailed was present in 13 (2.2%) patients and 12 (2.0%) were HIV positive. From all TB patients, 60.8% were smear-positive, 87.6% were new cases, and 87.3% of smear-positive patients were cured cases. Also, 23.6% patients had history of hospitalization for TB. More than half (55.4%) of TB patients were reported by public health system. Age-adjusted incidence rates of all TB cases during 2005–11 was 3.4, 3.2, 3.6, 4.7, 3.3, 4.4 and 7.3 in 100,000 respectively (C-A trend test, P< 0.001).
Conclusion Although, the incidence rate of TB in Hamadan Province is lower than country’s average, increasing trend of TB incidence is not concordant with its decreasing trend in Iran. An epidemiological study is required to evaluate risk factors associated with TB to identify ways to decrease the prevalence of TB.
1. World Health Organization (WHO). Tuberculosis. Geneva: WHO; 2013.
2. Center for Disease Control and Prevention, Ministry of Health and Medical Education, Iran. Tuberculosis status [Internet]. 2012. Available from: http://www.cdc.hbi.ir/TB_Situation_in_Iran.aspx.
3. World Health Organization (WHO). The global plan to stop TB 2011-2015: Transforming the fight towards elimination of tuberculosis. Geneva: WHO; 2010.
4. Harries AD, Dye C. Tuberculosis. Ann Trop Med Parasitol 2006; 5: 415–31.
5. World Health Organization (WHO). Global tuberculosis report 2012. Geneva: WHO; 2012.
6. Hassanzadeh J, Nasehi M, Rezaianzadeh A, Tabatabaee H, Rajaeifard A, Ghaderi E. Pattern of reported tuberculosis cases in Iran 2009-2010. Iran J Public Health 2013; 42: 72–8.
7. Marjani M, Baghaei P, Tabarsi P, Shamaei M, Mansouri D, Masjedi MR, et al. Drug resistance pattern and outcome of treatment in recurrent episodes of tuberculosis. East Mediterr Health J2012; 18: 957–61.
8. Nasehi M, Hassanzadeh J, Rezaianzadeh A, Zeigami B, Tabatabaee H, Ghaderi E. Diagnosis delay in smear positive tuberculosis patients. J Res Med Sci2012; 17: 1001–4.
9. Moradi M, Arababadi MK, Hassanshahi G. Tuberculosis in the Afghan Immigrants in Kerman Province of Iran. J Biol Sci2008; 8: 1107–9. doi: 10.3923/jbs.2008.1107.1109
10. World Health Organization (WHO). Treatment of Tuberculosis: Guidelines. Geneva: WHO; 2010.
11. World Health Organization (WHO). Global tuberculosis control: WHO report 2011. Geneva: WHO; 2011.
12. Salek S, Salek S, Emami H, Masjedi MR, Velayati AA. [Epidemiologic Status of Tuberculosis in Golestan Province]. Tanaffos2008; 7: 63–8.
13. Haghdoost AA, Mostafavi E, Mirzazadeh A, Navadeh S, Feizzadeh A, Fahimfar N, et al. Modelling of HIV/AIDS in Iran up to 2014. JAHR2011; 3: 231–9.
14. Muniz JN, Ruffino-Netto A, Villa TC, Yamamura M, Arcencio R, Cardozo-Gonzales RI. Epidemiological aspects of human immunodeficiency virus/tuberculosis co-infection in Ribeirão Preto, Brazil from 1998 to 2003. J Bras Pneumol 2006; 32: 529–34. doi: http://dx.doi.org/10.1590/S1806-37132006000600010
15. Liu J, Lü B, Yan Y. Meta analysis on the co-infection between Mycobacterium tuberculosis and HIV/AIDS in China. Zhonghua Liu Xing Bing Xue Za Zhi 2013; 34: 85–90.
16. Chehab JC, Vilakazi-Nhlapo AK, Vranken P, Peters A, Klausner JD. Current Integration of Tuberculosis (TB) and HIV Services in South Africa, 2011. PLoS One2013; 8: e57791. doi: 10.1371/journal.pone.0057791
17. Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, Shearer S. HIV and pulmonary tuberculosis: the impact goes beyond those infected with HIV. AIDS2004; 18: 657–62.
18. Rezaeian S, Esmailnasab N. Social Determinants of Health Associated with Self-Reported HIV Testing among Women. Iran J Public Health 2013; 42: 436–42.
19. Kaboru BB, Ogwang BA, Namegabe EN, Mbasa N, Kabunga DK, Karafuli K. TB/HIV co-infection care in conflict-affected settings: a mapping of health facilities in the Goma area, Democratic Republic of Congo. Int J Health Policy Manag 2013; 1: 207–11. doi: 10.15171/ijhpm.2013.38
20. Lienhardt C, Fielding K, Sillah JS, Bah B, Gustafson P, Warndorff D,et al. Investigation of the risk factors for tuberculosis: a casecontrol study in three countries in West Africa. Int J Epidemiol 2005; 34: 914–23.
21. Atre S, Kudale A, Morankar S, Gosoniu D, Weiss MG. Gender and community views of stigma and tuberculosis in rural Maharashtra, India. Glob Public Health2011; 6: 56-71. doi: 10.1080/17441690903334240
22. Liberato IR, de Albuquerque Mde F, Campelo AR, de Melo HR. Characteristics of pulmonary tuberculosis in HIV seropositive and seronegative patients in a Northeastern region of Brazil. Rev Soc Bras Med Trop2004; 37: 46–50. doi: http://dx.doi.org/10.1590/S0037-86822004000100012
23. Codlin AJ, Khowaja S, Chen Z, Rahbar MH, Qadeer E, Ara I, et al. Short report: gender differences in tuberculosis notification in Pakistan. Am J Trop Med Hyg2011; 85: 514–7.
24. Glynn JR, Crampin AC, Yates MD, Traore H, Mwaungulu FD, Ngwira BM, et al. The importance of recent infection with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in Northern Malawi. J Infect Dis 2005; 192: 480–7. doi: 10.1086/431517
25. Dewan PK, Lal SS, Lonnroth K, Wares F, Uplekar M, Sahu S, et al. Improving tuberculosis control through public-private collaboration in India: literature review.BMJ2006; 332: 574–8.
26. Sehgal S, Dewan PK, Chauhan LS, Sahu S, Wares F, Granich R. Public-private mix TB activities in Meerut, Uttar Pradesh, North India: delivering dots via collaboration with private providers and non-governmental organizations.Indian J Tuberc2007; 54: 79–83.
27. Masjedi MR, Fadaizadeh L, Taghizadeh Asl A. Notification of patients with tuberculosis detected in the private sector, Tehran, Iran. Int J Tuberc Lung Dis 2007; 11: 882–6.